Suppr超能文献

蛋白质 S:血液凝固的中央调节因子。

Protein S: a Central Regulator of Blood Coagulation.

出版信息

Clin Lab. 2022 Aug 1;68(8). doi: 10.7754/Clin.Lab.2021.211010.

Abstract

BACKGROUND

Protein S is a central regulator of coagulation as it critically participates in down-regulation of both extrinsic and intrinsic pathways of the coagulation cascade. In this review, we aim to provide an update on protein S and its anticoagulant functions as a central hemostatic regulator.

METHODS

Electronic databases including, Google, Google Scholar, PMC, PubMed, Science Direct, and Scopus were rigorously searched using the terms protein S, hemostasis, natural anticoagulants, regulators of coagulation, and coagulation inhibitors for the completion of this descriptive review.

RESULTS

Literature review shows that protein S is a potent cofactor for activated protein C (APC) in the regulation of the intrinsic pathway and a cofactor for tissue factor pathway inhibitor (TFPI) in the regulation of the extrinsic pathway. The strong association between protein S deficiency either hereditary or acquired and increased risk for venous thrombosis indicates the important and central role of protein S in controlling the initiation and propagation phase of coagulation cascade and that protein S is an important determinant for optimal activity of both APC and TFPI in coagulation regulation.

CONCLUSIONS

Available evidence suggests that the role of protein S in the down-regulation of blood coagulation is mainly mediated through its high affinity binding to negatively charged phospholipid surfaces. This high affinity binding to negatively charged phospholipids helps bring the anticoagulant proteins to the membranes, resulting in efficient and targeted regulation of coagulation. In the shade of current COVID-19 pandemic, protein S deficiency has been found to be a leading cause of thrombotic complications associated with COVID-19.

摘要

背景

蛋白 S 是凝血的核心调节因子,因为它在下调凝血级联的外源性和内源性途径方面起着至关重要的作用。在这篇综述中,我们旨在提供蛋白 S 及其抗凝功能的最新信息,作为核心止血调节剂。

方法

使用术语蛋白 S、止血、天然抗凝剂、凝血调节剂和凝血抑制剂,在 Google、Google Scholar、PMC、PubMed、Science Direct 和 Scopus 等电子数据库中进行了严格搜索,以完成这篇描述性综述。

结果

文献综述表明,蛋白 S 是激活蛋白 C(APC)在调节内源性途径和组织因子途径抑制剂(TFPI)在调节外源性途径中的有效辅因子。蛋白 S 缺乏无论是遗传性还是获得性的,与静脉血栓形成风险增加之间存在强烈关联,这表明蛋白 S 在控制凝血级联的起始和传播阶段方面起着重要和核心作用,并且蛋白 S 是 APC 和 TFPI 在凝血调节中的最佳活性的重要决定因素。

结论

现有证据表明,蛋白 S 在下调血液凝血中的作用主要是通过其与带负电荷的磷脂表面的高亲和力结合来介导的。这种与带负电荷的磷脂的高亲和力结合有助于将抗凝蛋白带到膜上,从而有效地靶向调节凝血。在当前 COVID-19 大流行的阴影下,已经发现蛋白 S 缺乏是与 COVID-19 相关的血栓并发症的主要原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验